DBV Technologies | DBVT - Ebit





Ebit تغيير تاريخ
Acadia Pharmaceuticals USD -4.62M 22.01M 2026-03
Alnylam Pharmaceuticals USD 112.6M 24.99M 2026-06
Amarin USD -2.26M 564K 2025-12
BioCryst Pharmaceuticals USD 260.38M 230.79M 2025-12
BioMarin Pharmaceutical USD 129.65M 68.74M 2026-03
DBV Technologies USD -47.9M 2.85M 2026-03
Galectin Therapeutics USD -9.17M 163K 2023-09
Halozyme Therapeutics USD -61.77M 26.64M 2026-03
Incyte USD 700.4M 356.23M 2026-06
Insmed USD -200.28M 49.43M 2026-03
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
Neurocrine Biosciences USD 219.9M 5.3M 2026-06
PTC Therapeutics USD 45.89M 127.51M 2026-03
Sarepta Therapeutics USD 358.43M 768.52M 2026-03
Ultragenyx Pharmaceutical USD -216M 102M 2026-03
United Therapeutics USD 325.8M 340.4M 2026-03